Financial Times Europe 04Mar2020

(Joyce) #1
10 ★ FINANCIAL TIMES Wednesday4 March 2020

The Big Mac is used to measure
purchasing power worldwide. The
sausage roll might equally serve as a
pastry-encased barometer for life in
the UK.Greggs, the biggest purveyor, is
buffeted and buoyed by the economy, a
whimsical tax regime and the variable
weather. Like the stoic Brits it serves, it
soldiers on.
Coming off a strong year, with
pre-tax profits up 27 per cent before
exceptionals to £114.2m, the
fast-growing food retailer has had a
flaky start to 2020. Comparable sales in
stores it manages grew just 7.5 per cent
in the first two months of the year.
ebruary storms and flooding,F
which temporarily closed a plant in
Wales, were among the culprits. This
year will see a spike in input costs.
Wages are due to rise about 4 per cent.
Pork is set to drive a 7 per cent increase
in ingredient costs, which account for
almost a third of the total.
Coronavirus, which has taken a
swipe at everything from airlines to
fashion, will not leave sausage rolls
unscathed. The very concept of “food-
to-go” is at odds with a virus-fearing
world where no one goes anywhere.
Fear not. The ride may be bumpy.
But the secret sauce of this vendor of
cheap snacks is a northern trait: thrift.
The company is spending on new
plants and shops. It opens stores at a
rate of about 100 a year. The company
will invest around £90m a year as it
upgrades older outlets.
To ease the burden, Greggs aims to
claw back about £20m from site
disposals. The investment should
deliver recurring savings of £9.5m off
the 2015 base. Investors can take
further comfort from the group’s
progressive dividend policy. Last year’s
44.9p dividend was up by a quarter.
This year’s payout could be
accompanied by a special distribution.
The shares, down 5 per cent this
year, have outperformed the FTSE 250
over one and three years. There is

Greggs:
stormproof sausage role

nothing fancy about Greggs or its
sausage rolls. But in both cases,
familiarity breeds content.

Sporting events account for
three-quarters of the most-watched TV
broadcasts of all time. Football features
heavily. That has spurredFifa ot
propose expansion of the Club World
Cup, a sideshow in the global game.
Gianni Infantino, president of the
governing body, thinks this is a great
idea. Others do not. The key question is
what thetournament might be worth.
If the value is high, financing should
follow, justifying his optimism. The

Fifa/Club World Cup:
Gianni come lately

project would mean expanding an
eight-team event into a 25-club
competition. Mr Infantino thinks he
can raise $1bn for this, a third less than
the figure he floated two years ago.
The problem is that football is a
mature industry. Much of its revenue
comes from selling media rights.
Broadcasters are reluctant to spend
more. They have already made some
club owners and players wealthy,
notably in the English Premier League.
This generated nearly £5bn of revenue
in the 2017-18 season.
The Premiership and the Champions
League do not welcome outside
investors. Some clubs do, providing a
gauge of what an expanded Club World
Cup might be worth.Arsenal nda
Manchester United re valued at justa
over 4 times revenues.CVC olds

control of theFormula One acingr
franchise in a deal worth $8bn, also
about 4 times annual sales. The firm
plans to recycle its profits into rugby.
Having bought a stake in Premiership
Rugby it wants to take a stake in the
Six Nations contest for £300m.
That suggests a £2.1bn valuation.
Mr Infantino’s venture might be in the
same ballpark, supposing he got $1bn
for a stake in the club tournament, say
40 per cent. Projected annual sales
would need to be about $500m to align
with F1 and famous football clubs.
But hold hard. We are comparing
apples with pears — or perhaps football
and rugby balls. A contest sketched on
the back of a programme is worth far
less than established teams and
tournaments. Mr Infantino looks set to
revise his numbers down yet again.

Exchange traded funds have exploded
in popularity in recent years. So have
warnings on thesystemic risks heyt
may pose. Michael Burry, one of the
investors made famous by Michael
Lewis’s bookThe Big Short, caused a stir
last year byarguing hat the $4.4tn USt
ETF industry is a massive bubble.
He likened ETFs to toxic
collateralised debt instrument that he
shorted ahead of the financial crisis.
Coronavirus-induced market turmoil
has put the mechanics of ETFs to the
test. The fear was that investors would
panic and sell all at once. Huge
concentrations of securities within
certain funds could then make markets
seize up, trapping investors. The
largest US stock and bond ETFs have
experienced some of theirmost active
trading days n record in recent days.o
No large funds imploded.
One reason: money was shuffling
round ETFs rather than pulling out.
Investors ditched equity funds and
bought into fixed-income funds.
Over 80 per cent of outflows in the
first four days of last week came from
just one ETF, according to data
provider First Bridge. This wasState
Street’s SPY, which tracks the S&P 500.
It is the world’s biggest ETF and has
one of the most liquid shares. No
danger of an implosion there, it turns
out. A disorderly sell-off seems more
likely if the pattern was reversed and
there was an exodus from ETFs holding
illiquid bonds into equities.
But the bigger risk to investors, it
turned out, was a systems failure at a
financial services business. Upstart
zero-fee trading platformRobinhood
went offline for 17 hours on Monday. Its
server infrastructure appears to have
struggled with the massive trading
volume. The system crash meant its
more than 10m users could no longer
use it to buy or sell stocks. Hardly ideal
given that the S&P 500 clocked up its
biggest rally since December 2018.
The danger of systemic financial
collapse gets doomsayers like Mr Burry
excited. Prosaic IT glitches are a more
dependable source of disruption.

ETFs/coronavirus:
Robinhood’s big misfire

The nice thing about having an
ex-investment banker as chief financial
officer is that she can advise you on the
benefits of external capital.Google
parentAlphabet its on a cash hoard ofs
$120bn. So the business and its
affiliates hardly need third-party
funding. It has nevertheless assembled
$2.25bn from a consortium for its
autonomous vehicle unit,Waymo.
For Google CFORuth Porat t musti
feel quite like old times. Until now,
Alphabet had used only its balance
sheet to fund Waymo. Taking funds
from others makes sense. It is a
formula that the tech giant can apply
across its portfolio of “moonshots”.
Driverless cars will not beviable for
years. Technology, regulation and
customer acceptance are among the
barriers. Huge capital investment is
required. It is smart not only to share
the costs but also to tap the expertise of
other sophisticated investors.
Like any task force in an action
movie, the partners bring different
capabilities to the mission. US car
retailerAutoNation nd parts makera
Magna ontribute knowledge of thec
automotive supply chain.Silver Lake
Partners knows its way round tech
investment whileMubadala nd thea
Canada Pension Plan nvestment BoardI
have deep pockets and the willingness
to wait years for returns.
Waymo did not disclose an implied
valuation of the business. Last year’s
fundraising byCruise ffers some clueso
with the round featuringSoftBank nda
T Rowe Price, valuingGeneral Motors’
autonomous vehicle unit at $19bn.
Analysts have pegged a similar number
for Waymo. But such valuations risk
creating false certainties when
commercial prospects are so distant.
Strategic investors simply want a place
at the table if and when a market
develops. As for financial investors,
with US benchmark interest rates now
teasing zero, deeply speculative
prospects suddenly look tame.
There is no doubt that autonomous
vehicles are a potentially
transformational technology. The
contrast, naming no names, is with
companies that sublet office space or
sell mattressesonline. Alphabet
investors should meanwhile welcome
proof of the clout their company’s cash

Google: carpool for a
driverless moonshot

balance and technical knowhow
creates. Co-investors increase the
chances its ventures will succeed.
Equally,external investors validate
moonshots that might otherwise look
like billionaires’ vanity projects.

CROSSWORD
No. 16,416 Set by JULIUS

 

 

 

  

   

  

 

 

JOTTER PAD


ACROSS
1 Spooner’s resentful convicts
found down in the dumps (6,4)
7 Nobleman almost naked (4)
9 Creature seen in our ocean
frequently (4)
10 Toxic, explosive articles stirring
up Brits by Dom (5,5)
11 Energy saved by support bod
working in IT (6)
12 Strongly criticise Ms Moore,
about to become viral
worldwide? (8)
13 Notorious individual describing
one stuffed with 1? (3,5)
15 Leader of Italian resistance unit
retired, giving modest address
(4)
17 Sun’s leader, page 4, such a
disreputable character! (4)
19 Discuss loftier garret of priests
(8)
22 The Duke of Milan’s quite
correct to defend son, Oscar (8)
23 France pitching in to recycle
garbage (6)
25 Bra – letter G – tailored item of
ladies underwear (6,4)
26 Hear end of story (4)
27 At a knockdown price, Charlie
shifted pile (4)
28 Participates vocally in
hairdressing salon gossip (5,5)
DOWN
2 National Inquirer’s no.1 serial
criminal (7)
3 Waste time being over-hasty (5)

4 Embarrassed leaders such as
Kinnock and Kennedy? (8)
5 Insignificant event preceding
tsunami (1,4,2,3,5)
6 Working with intelligence, start
to plant yard with grass border
(6)
7 I see actor throwing out
collection of arcane items (9)
8 Poor Bobbie regularly given the
run around (7)
14 Copies Riley doing real-time
tummy exercise? (5,2,2)
16 Litter? New duster will collect it
(8)
18 Rising salesman Dave
struggling to spread effectively
(7)
20 Puttin’ down timeless drug (7)
21 Conclude Bristol is packed with
dross (6)
24 Deadly river claiming reserves
(5)

32 ( 75 < , 1027 , 21
( ; 2 % , 3 ' ,
$*,7$7,1* 35 ,6 0
6 6 0 * * 5 2 %
$/72 3$5$1250$/
1 ( , 0 5 % (
7(1$1&< '256$/
6 & 7 , 1 )
5(&(66 7681$0,
5 5 & $ 0 / 1
(63(&,$//< $*2*
9 ( ( 5 / / ( (
2:1(' 352)(66 25
/ & ( ( : 6 , (
75 ($ 685 ( , 6 /$ 1 '

Solution 16,

Wind speeds in KPH Scale:
x = 55.
y = 50.

HIGH

HIGH

LOW
OCCLUDED FRONT LINE


WARM FRONT LINE

COLD FRONT LINE

ISOBAR BRUSH FRONT SYMBOLS

PRESSURE LABELS

1040 1040

1030 1030

1020

1020

1020

1020

1010
1010

1010

1000

1000

1000

990

990

990

980 980

970 970

960 960

950 950

940 940

xxNAMExx

LOW

LOW

Malta Shower 16
Manila Fair 32
Miami Fair 30
Milan Sun 15
Montreal Fair 5
Moscow Cloudy 8
Mumbai Sun 30
Munich Cloudy 7
Naples Fair 14
New York Sun 14
Nice Fair 14
Nicosia Sun 22
Oslo Snow 3
Paris Rain 7
Prague Fair 7
Reykjavik Snow 1
Riga Drizzle 8
Rio Rain 27
Rome Sun 16
San Francisco Sun 21
Singapore Fair 33
Stockholm Sleet 4
Strasbourg Cloudy 10
Sydney Rain 25
Tokyo Shower 9
Toronto Cloudy 6
Vancouver Fair 9
Vienna Fair 11
Warsaw Cloudy 9
Washington Sun 17
Zagreb Cloudy 12
Zurich Fair 8

Amsterdam Cloudy 9
Ankara Fair 18
Athens Shower 17
Bahrain Sun 21
Barcelona Fair 17
Beijing Sun 7
Belfast Shower 7
Belgrade Shower 9
Berlin Cloudy 8
Brussels Rain 9
Budapest Cloudy 9
Cairo Sun 27
Cardiff Rain 8
Chicago Fair 8
Cologne Cloudy 10
Copenhagen Shower 7
Delhi Sun 27
Doha Sun 24
Dubai Sun 23
Dublin Rain 6
Edinburgh Cloudy 7
Frankfurt Cloudy 9
Geneva Cloudy 10
Hamburg Shower 8
Helsinki Snow 4
Hong Kong Rain 22
Istanbul Fair 18
Lisbon Cloudy 18
London Rain 8
Los Angeles Sun 21
Luxembourg Cloudy 7
Madrid Fair 19

Today’s temperatures

Forecasts by
Wind speed
in KPH

16

24 32

7

6

8

(^1819)
25
21
19
14
7
7
9
3
3
4
8
16
20
13
15
16
12
8
6
8 9
9
17
(^2026)
22
17
16
Lex on the web
For notes on today’s breaking
stories go towww.ft.com/lex
Twitter: @FTLex
You could assume coronavirus
nudgedThermo Fisher cientific intoS
bidding forQiagen. You would be
wrong. TheEuropean target has just
released a new test for Covid-19. But
Qiagen was the subject of takeover
rumours well before the outbreak.
Thermo Fisher of the US was already
top of the list of suitors.
Big US scientific equipment groups
such as Thermo Fisher andDanaher
are on a consolidation spree, buying
small, specialised bolt-ons. Qiagen,
whose real métier is DNA testing, fits
that bill. It has scarcity value and
little overlap with its purchaser. This
should ease regulatory scrutiny.
The offer of €39 per share values
Qiagen at just over €10bn, including
net debt. That is 20 times forecast
ebitda and includes a 23 per cent
premium to the undisturbed share
price. It is a fancier valuation than the
shares have ever commanded.
Planned annual cost savings of
€135m fall short of covering the €1.6bn
premium by about €400m, once taxed
and capitalised. That probably reflects
a lack of public targets in a
fast-consolidating sector rather than a
pandemic-induced bid. Qiagenis
unlikely to get a better offer.
The paucity of potential cost savings
reflects Qiagen’s efficiency. Its ebitda
margins before exceptionals hit 36 per
cent last year. The company still
wound up with a €37m net loss, as a
result of €273m in writedowns related
to DNA sequencing research.Peer
Schatz tepped aside as chiefs
executive. Those problems aside,
Qiagen is a sound proposition. The
bulk of revenues come from lab
equipment that drug and biotech
researchers rely on. he strategicT
value of Qiagen helps justify the
steep price.
The recommended tender offer
nudges the spotlight on to Europe’s
remaining independent mid-cap
medical equipment groups. These
includeDiaSorin f Italy and France’so
BioMérieux. Shares in both received
a 4 per cent bump from news of the
Qiagen’s deal.
Providing the tools and equipment
to fight the world’s diseases and
infections has long been about scale.
At most, coronavirus may have
hastened consolidation.
FT graphic Sources: Dealogic; FT Research; S&P Global
Qiagen bid
bn
Premium
Cost savings
taxed and
capitalised
    
Qiagen valuation
Enterprise value to forward ebitda


























     


Apr 

Feb 

May 

Mar 

Feb 

May 

May 






















Deal
value
(bn)

Announcement
Date

Acquiror Target

Medical equipment related M&A deals -


Becton Dickinson

Danaher

Danaher

CR Bard

GE Biopharma

Pall

Qiagen

Alere

Patheon

VWR























Thermo Fisher Scientific

Avantor Performance
Materials

Thermo Fisher Scientific

Abbott Laboratories

Enterprise
value/ebitda

Qiagen/Thermo Fisher: white-coat wedding
Scientific devices group Thermo Fisher is buying Qiagen, which makes lab-testing kit. The deal follows
a consolidation wave in the sector as big groups buy smaller specialists. The premium fully values Qiagen —
a reflection of its scarcity value — and is unlikely to be covered by the expected cost savings.

MARCH 4 2020 Section:FrontBack Time: 3/3/2020- 19:00 User:nick.miller Page Name:1BACK, Part,Page,Edition:EUR, 10, 1

Free download pdf